Table 1 Correlation between the expression of pFOXO1A and clinicopathological factors in human gastric cancer
pFOXO1A positive (%) | pFOXO1A negative (%) | P-value | |
|---|---|---|---|
Total (n=272) | 230 (85) | 42 (15) | |
Age (years) | |||
0–39 | 37 (90) | 4 (10) | 0.495 |
40–65 | 143 (83) | 29 (17) | |
66–99 | 50 (85) | 9 (15) | |
Gender | |||
Male | 158 (86) | 26 (14) | 0.387 |
Female | 72 (82) | 16 (18) | |
Location | |||
Antrum | 121 (85) | 22 (15) | 0.978 |
Body and cardia | 109 (84) | 20 (16) | |
Lauren's classification | |||
Intestinal | 96 (94) | 6 (6) | 0.001* |
Diffuse | 131 (79) | 35 (21) | |
Mixed | 3 (75) | 1 (25) | |
TNM stage | |||
I | 107 (96) | 5 (4) | <0.001* |
II | 42 (79) | 11 (21) | |
III | 49 (78) | 14 (22) | |
IV | 32 (73) | 12 (27) | |
Lymphatic invasion | |||
Absent | 168 (88) | 23 (12) | 0.017* |
Present | 62 (77) | 19 (23) | |
Lymph node metastasis | |||
Absent | 94 (96) | 4 (4) | <0.001* |
Present | 136 (78) | 38 (22) | |
Distant metastasis | |||
Absent | 220 (86) | 37 (14) | 0.063 |
Present | 10 (67) | 5 (33) | |
